Surinabant

DB13070InvestigationalSmall molecule

Surinabant has been investigated for the treatment of Smoking Cessation.

Mechanism: Pharmacologically active on Cannabinoid receptor 1
Curator reviewed
Formula / weight: C₂₃H₂₃BrCl₂N₄O · 522.27 g/mol (avg)
Code names: SR-147778

Resolves to

Compound

Structure

InChIKeyHMXDWDSNPRNUKI-UHFFFAOYSA-NSMILESCCC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Br)C=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

841Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Surinabant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.